UPDATE ON COVID-19 VACCINE Trial
For all information and enquiries regarding the COVID-19 vaccine trial, please visit: https://covid19vaccinetrial.web.ox.ac.uk/.
SUPPORT OXFORD’S COVID-19 VACCINE RESEARCH
Funding for Oxford’s COVID-19 vaccine research requires unprecedented speed, scope and ambition. Support from Government, corporations, trusts and foundations will be crucial to the development of a vaccine to combat the new virus. Alongside those traditional sources of funding, philanthropic donations of any size will have real and rapid impact, allowing us to accelerate this time-critical research, and ensure that Oxford’s vaccine solution will be as effective and swift as possible.
If you are interested in supporting this effort, please make a gift here.
Monday, 06 December 2021, 3pm to 4pm
Roope LSJ. et al, (2021), Health Research Policy and Systems, 19
Ogbe A. et al, (2021), Nature Communications, 12
The University moved to Business Continuity Plan (BCP) Level 1 on Monday 6 September, enabling all staff to return to working on site. Please refer to our Health page for details of the University’s updated health guidance
The hard work and swift adaptability of staff during the pandemic has ensured continuity for our students and researchers, and allowed the University to continue to succeed through what has been a very challenging period. The move to BCP Level 1 brings the University in line with Step 4 of the UK government’s roadmap, allowing for in-person learning and assessment wherever possible, a return to working on site for all staff, and increased public access to University and college facilities. It also means the removal of most COVID-19 restrictions in place at the University.